MANNING ANTHONY M. (Chief Scientific Officer) sold 18.9% of their position (6.81K shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $239.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2020ACC: 0001104659-20-080015
Officer· Chief Scientific Officer
Since Oct 2018
+23.19K
Net shares
Net buyer
$239.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 6.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
71.4%
6/29/2020
21K→36K
Common Stock
Direct
Shares
−6.81K
Price / share
$35.10
Trade value
$239.07K
% of position
18.9%
6/30/2020
36K→29.19K
Total
Net shares
+8.19K
Net value
-$239.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2020 | A · Award | +15K | — | — | 71.4% | 21K | 36K |
| Common Stock Direct | 6/30/2020 | S · Sale | −6.81K | $35.10 | $239.07K | 18.9% | 36K | 29.19K |
| Total | +8.19K | -$239.07K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
Held after
45K
Exercisable
—
6/29/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock15K shares | 6/29/2020 | A · Award | +15K | — | 45K |